Augmentation Strategies to Improve Treatment of Major Depression

E-ISSN： 1875-6166|6|2|135-152

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.6, Iss.2, 2006-01, pp. : 135-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Catecholaminergic Strategies for the Treatment of Major Depression

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 149-158

Bentham Science Publishers

Access to resources Recommend Favorite

Quetiapine augmentation in treatment-resistant depression: a naturalistic study

By Šagud Marina Mihaljević-Peleš Alma Mück-Šeler Dorotea Jakovljević Miro Pivac Nela

Psychopharmacology, Vol. 187, Iss. 4, 2006-09 ,pp. : 511-514

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Mechanisms of Action of Lithium Augmentation in Refractory Major Depression

Current Pharmaceutical Design, Vol. 12, Iss. 23, 2006-08 ,pp. : 2985-2992

Bentham Science Publishers

Access to resources Recommend Favorite

Risk of Adverse Events with the Use of Augmentation Therapy for the Treatment of Resistant Depression

By Schweitzer I. Tuckwell V.

Drug Safety, Vol. 19, Iss. 6, 1998-12 ,pp. : 455-464

Adis International

Access to resources Recommend Favorite

Augmentation therapy with alpha-lipoic acid and desvenlafaxine: A future target for treatment of depression?

By Silva Márcia Sousa Caren Sampaio Luis Ximenes Naiara Araújo Paulo Silva Jéssica Oliveira Suzyana Sousa Francisca Macêdo Danielle Vasconcelos Silvânia

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 386, Iss. 8, 2013-08 ,pp. : 685-695

Springer Publishing Company

Access to resources Recommend Favorite